DGAP-Media / 18.12.2015 / 11:05 Press Release Medisana AG: Intent of public takeover offer from Xiamen Comfort Science & Technology Group Co., Ltd. for Medisana AG shares Neuss, 18. December 2015 - The Xiamen Comfort Science & Technology Group Co., Ltd. ("Easepal"), the leading Chinese enterprise in the healthcare industry spanning the full industry value chain including research & development, manufacturing, branding and marketing, today announced its intent to make a voluntary public takeover offer to the shareholders of Medisana AG ("Medisana") (ISIN DE0005492540, WKN 549 254), one of Germany's leading consumer healthcare products companies, through its German subsidiary Comfort Enterprise (Germany) GmbH. The voluntary public takeover offer to the Medisana shareholders will be made at an offer price of 2.80 EUR cash per share. This represents a premium of 14.3% to Medisana's closing share price on December 17, 2015 and of 3.5% on the three-month volume weighted average price (XETRA). Concurrently, Easepal has entered into an agreement to acquire a 75.31% stake in Medisana from a group of major shareholders. This group includes Medisana's largest shareholder and CEO Ralf Lindner as well as the chairman of the supervisory board, Thies Goldberg. Ralf Lindner indirectly will take a stake in the company by reinvesting as part of the transaction. Besides he will continue in his role as CEO. In accordance with Section 10 WpÜG, Easepal has published a statutory announcement of a voluntary public takeover offer and intends to publish the offer document describing detailed terms and conditions of the offer to Medisana's shareholders following approval by the German Federal Financial Supervisory Authority (BaFin). Easepal anticipates completing the offer in March. Medisana, together with its subsidiaries, develops, markets, and sells home and mobile healthcare products for health-conscious consumers worldwide. Particularly the areas of connected healthcare products and mobile health are expected hold significant growth potential for the company. Medisana and Easepal have successfully build a strong and trusting business relationship over the last years. The acquisition is part of Easepal's internationalization strategy and is planned to provide significant benefits to both parties including the accelerated development of new products and mobile applications, expanded market reach and product assortments as well as optimized sourcing. MEDISANA AG Jagenbergstrasse 19, 41468 Neuss, Germany Tel.: +49 (0) 2131 / 36 68 0 Fax: +49 (0) 2131 / 36 68 50 95 [email protected] www.medisana.de UBJ. GmbH Kapstadtring 10, 22297 Hamburg T.: +49 (0) 40 6378 5410 F.: +49 (0) 40 6378 5423 [email protected] www.ubj.de End of Media Release --------------------------------------------------------------------------- Issuer: Medisana AG Key word(s): Enterprise 18.12.2015 Dissemination of a Press Release, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Medisana AG Jagenbergstr. 19 41468 Neuss Germany Phone: +49 (0)2131-3668 5410 Fax: +49 (0)2131- 3668 5095 E-mail: [email protected] Internet: www.medisana.de ISIN: DE0005492540 WKN: 549254 Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart End of News DGAP Media --------------------------------------------------------------------------- 424955 18.12.2015